Scienture Holdings, Inc.(SCNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SCNX Scienture Holdings, Inc.

已收盘 07-16 16:00:00 EDT

0.4138

+0.0058

+1.42%

盘后0.3997

-0.0141-3.41%

19:35 EDT

最高0.4250	最低0.3990	成交量61.09万
今开0.3991	昨收0.4080	日振幅6.37%
总市值1,681万	流通市值1,385万	总股本4,063万
成交额25.15万	换手率1.82%	流通股本3,348万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":0.4138,"timestamp":1784232000000,"preClose":0.408,"halted":0,"volume":610921,"hourTrading":{"tag":"盘后","latestPrice":0.3997,"preClose":0.4138,"latestTime":"19:35 EDT","volume":21050,"amount":8524.7605,"timestamp":1784244938529,"change":-0.0141,"changeRate":-0.034074,"amplitude":0.038475},"delay":0,"changeRate":0.014215686274509871,"floatShares":33482217,"shares":40630815,"eps":-2.45,"marketStatus":"已收盘","change":0.0058,"latestTime":"07-16 16:00:00 EDT","open":0.3991,"high":0.425,"low":0.399,"amount":251505.3623983,"amplitude":0.063725,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.45,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1784275200000},"marketStatusCode":5,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":0.408,"preHourTrading":{"tag":"盘前","latestPrice":0.399,"preClose":0.408,"latestTime":"09:27 EDT","volume":11488,"amount":4558.92158528,"timestamp":1784208452463,"change":-0.009,"changeRate":-0.022059,"amplitude":0.070098},"postHourTrading":{"tag":"盘后","latestPrice":0.3997,"preClose":0.4138,"latestTime":"19:35 EDT","volume":21050,"amount":8524.7605,"timestamp":1784244938529,"change":-0.0141,"changeRate":-0.034074,"amplitude":0.038475},"volumeRatio":0.04098},"requestUrl":"/m/hq/s/SCNX","defaultTab":"news","newsList":[{"id":"1197083931","title":"Scienture公布2026年第一季度财报：营收强劲增长，毛利率显著扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=1197083931","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197083931?lang=zh_cn&edition=full","pubTime":"2026-05-18 20:39","pubTimestamp":1779107951,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.发布了2026年第一季度财务业绩及业务进展。报告期内，公司实现了显著的营收增长，同时毛利率亦获得有力扩张，展现出强劲的业务发展势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143008554","title":"Scienture Holdings与Summit Biosciences达成最终协议 获得Rezenopy美国独家商业化权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1143008554","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143008554?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:14","pubTimestamp":1778156056,"startTime":"0","endTime":"0","summary":"Scienture Holdings已与Summit Biosciences签署最终协议，获得抗抑郁药物Rezenopy在美国市场的独家商业化权利。此次合作将进一步加强Scienture Holdings在神经科学领域的市场布局。\n根据协议条款，Scienture Holdings将负责Rezenopy在美国境内的所有商业化活动，包括市场推广、销售和分销。该交易标志着公司向精神健康治疗领域迈出重要一步。\nRezenopy作为一种新型抗抑郁药物，在临床试验中展现出良好的疗效和安全性。此次独家授权协议的达成，将为Scienture Holdings带来新的收入增长点，并扩大其产品管线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178090977","title":"Scienture获得1100万美元非稀释性债务融资 加速已获批产品组合扩张及研发管线推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1178090977","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178090977?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:06","pubTimestamp":1778155590,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc. (简称Scienture) 近日成功获得1100万美元非稀释性债务融资。此次融资将主要用于加速公司已获批产品组合的商业化增长，并推动研发管线的持续进展。非稀释性融资模式使得Scienture能够在不动用股权的情况下获得资金支持，有效保护了现有股东利益。这笔资金将助力公司扩大市场份额，加强产品创新，为长期发展注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164857739","title":"Scienture Holdings获纳斯达克180天宽限期 需在此期间恢复最低股价合规要求","url":"https://stock-news.laohu8.com/highlight/detail?id=1164857739","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164857739?lang=zh_cn&edition=full","pubTime":"2026-04-15 20:05","pubTimestamp":1776254717,"startTime":"0","endTime":"0","summary":"纳斯达克交易所已正式授予Scienture Holdings, Inc.额外180天的宽限期，该公司须在此期间内将其股价提升至1美元以上，以满足交易所的最低报价规定。\n此次延期为这家生物科技企业提供了关键缓冲期，使其能够通过战略调整或业务优化等方式重新达到上市标准。若未能按时合规，公司将面临退市风险。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176660109","title":"Scienture Holdings, Inc.通过集团采购协议扩大Rezenopy™的商业可及性，覆盖全美超5,000家机构","url":"https://stock-news.laohu8.com/highlight/detail?id=1176660109","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176660109?lang=zh_cn&edition=full","pubTime":"2026-03-11 20:13","pubTimestamp":1773231202,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc. (SCNX) 已成功拓展其旗舰产品Rezenopy™的商业覆盖范围。该产品是当前获得美国食品药品监督管理局（FDA）批准的最高剂量纳洛酮鼻喷雾剂。通过达成一系列集团采购组织（GPO）协议，公司显著提升了这款关键药物的市场可及性。\n此次合作将直接惠及美国境内超过5,000家医疗机构，包括医院、诊所和社区健康中心等。此举旨在确保更多有需要的人群能够及时获得这种高效的阿片类药物过量逆转疗法。Rezenopy™的高剂量特性为其在紧急情况下快速起效提供了保障，对应对阿片危机具有重要价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614009750","title":"Scienture Holdings, Inc.盘中异动 早盘股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614009750?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:43","pubTimestamp":1772116987,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日22时43分，Scienture Holdings, Inc.股票出现异动，股价快速拉升5.81%。截至发稿，该股报0.450美元/股，成交量5.4598万股，换手率0.13%，振幅4.47%。Scienture Holdings, Inc.股票所在的医药零售行业中，整体涨幅为0.00%。其相关个股中，Scienture Holdings, Inc.、Wellgistics Health, Inc.、Ridgetech, Inc.涨幅较大，Scienture Holdings, Inc.、Wellgistics Health, Inc.、石榴云医较为活跃，换手率分别为0.13%、0.03%、0.03%，振幅较大的相关个股有Scienture Holdings, Inc.、Wellgistics Health, Inc.、High Tide Inc.，振幅分别为4.47%、1.98%、1.17%。Scienture Holdings, Inc.公司简介：Scienture Holdings Inc 是一家综合性医疗服务和医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226224308a4cbfdd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226224308a4cbfdd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612490010","title":"Scienture Holdings, Inc.盘中异动 早盘股价大跌7.02%报0.403美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612490010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612490010?lang=zh_cn&edition=full","pubTime":"2026-02-17 22:32","pubTimestamp":1771338769,"startTime":"0","endTime":"0","summary":"北京时间2026年02月17日22时32分，Scienture Holdings, Inc.股票出现波动，股价大幅下跌7.02%。截至发稿，该股报0.403美元/股，成交量29.4963万股，换手率0.73%，振幅0.72%。Scienture Holdings, Inc.股票所在的医药零售行业中，整体涨幅为0.00%。其相关个股中，Petmed Express, Inc.、Ridgetech, Inc.、High Tide Inc.涨幅较大，Scienture Holdings, Inc.、High Tide Inc.、Petmed Express, Inc.较为活跃，换手率分别为0.82%、0.05%、0.02%，振幅较大的相关个股有Scienture Holdings, Inc.、Wellgistics Health, Inc.、High Tide Inc.，振幅分别为3.58%、1.87%、1.30%。Scienture Holdings, Inc.公司简介：Scienture Holdings Inc 是一家综合性医疗服务和医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217223250a4ad86ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217223250a4ad86ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119635143","title":"Scienture发布Arbli™商业进展：首款FDA即用型氯沙坦钾口服混悬液上市更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1119635143","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119635143?lang=zh_cn&edition=full","pubTime":"2026-02-03 21:05","pubTimestamp":1770123928,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.（简称Scienture）近日就其创新药物Arbli™的商业化进展发布最新动态。该产品作为全球首款获得美国食品药品监督管理局（FDA）批准的即用型氯沙坦钾口服混悬液，标志着高血压治疗领域的重要突破。\nArbli™的上市为无法吞咽标准片剂的患者提供了便捷解决方案，其即开即用的特性显著提升了用药依从性。公司正通过多渠道营销策略加速市场渗透，并与关键分销伙伴建立合作网络以扩大药品可及性。\n此次商业更新凸显了Scienture在心血管疾病治疗领域的研发实力。随着Arbli™逐步覆盖更多医疗机构的患者群体，公司有望进一步巩固其在专科药物市场的竞争优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606769374","title":"Scienture Holdings, Inc.盘中异动 大幅拉升5.51%报0.507美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606769374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606769374?lang=zh_cn&edition=full","pubTime":"2026-01-28 02:20","pubTimestamp":1769538021,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日02时20分，Scienture Holdings, Inc.股票出现异动，股价大幅拉升5.51%。Scienture Holdings, Inc.股票所在的医药零售行业中，整体涨幅为0.60%。其相关个股中，Scienture Holdings, Inc.、Wellgistics Health, Inc.、生研生物涨幅较大，Scienture Holdings, Inc.、Petmed Express, Inc.、Wellgistics Health, Inc.较为活跃，换手率分别为0.95%、0.47%、0.24%，振幅较大的相关个股有石榴云医、生研生物、Scienture Holdings, Inc.，振幅分别为7.11%、6.15%、5.66%。Scienture Holdings, Inc.公司简介：Scienture Holdings Inc 是一家综合性医疗服务和医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128022022a45d0ced&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128022022a45d0ced&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169867640","title":"Scienture获颁橙皮书可列专利 覆盖Rezenopy™——FDA批准用于抢救阿片类药物过量的最高剂量盐酸纳洛酮鼻喷雾剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1169867640","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169867640?lang=zh_cn&edition=full","pubTime":"2026-01-14 21:11","pubTimestamp":1768396264,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.宣布获得一项可列入橙皮书的专利授权，该专利覆盖其旗下产品Rezenopy™。这款鼻喷雾剂是经美国食品药品监督管理局批准、用于抢救阿片类药物过量急症的最高剂量盐酸纳洛酮制剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scientureholdings.com","stockEarnings":[{"period":"1week","weight":0.2311},{"period":"1month","weight":0.1324},{"period":"3month","weight":0.0462},{"period":"6month","weight":-0.2302},{"period":"1year","weight":-0.7614},{"period":"ytd","weight":-0.2}],"compareEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0},{"period":"3month","weight":0.0757},{"period":"6month","weight":0.0913},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Scienture Holdings, Inc.于2005年7月15日在特拉华州注册成立。该公司的主要运营子公司是Scienture，LLC。Scienture LLC是一家专业制药公司，专注于心血管（“CVS”）和中枢神经系统（“CNS”）疾病治疗产品的商业化和开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.119636},{"month":2,"riseRate":0.333333,"avgChangeRate":0.150517},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.073293},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.066727},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.09045},{"month":6,"riseRate":0.857143,"avgChangeRate":0.461559},{"month":7,"riseRate":0.714286,"avgChangeRate":0.106011},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.16799},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.047954},{"month":10,"riseRate":0,"avgChangeRate":-0.160548},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.067192},{"month":12,"riseRate":0,"avgChangeRate":-0.185859}],"exchange":"NASDAQ","name":"Scienture Holdings, Inc.","nameEN":"Scienture Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Scienture Holdings, Inc.(SCNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Scienture Holdings, Inc.(SCNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Scienture Holdings, Inc.,SCNX,Scienture Holdings, Inc.股票,Scienture Holdings, Inc.股票老虎,Scienture Holdings, Inc.股票老虎国际,Scienture Holdings, Inc.行情,Scienture Holdings, Inc.股票行情,Scienture Holdings, Inc.股价,Scienture Holdings, Inc.股市,Scienture Holdings, Inc.股票价格,Scienture Holdings, Inc.股票交易,Scienture Holdings, Inc.股票购买,Scienture Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Scienture Holdings, Inc.(SCNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Scienture Holdings, Inc.(SCNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}